Hypertension Clinical Trials in Philadelphia

Showing 181-200 of 218 trials

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

NCT01481077

The purpose of this study is to determine the effect of plug placement on the efficacy, safety and duration of effect of the L-PPDS (latanoprost punctal plug delivery system).

GlaucomaOcular Hypertension (OH)

Mati Therapeutics Inc.77 participantsStarted Nov 2011

Springdale, Arkansas, United States • Denver, Colorado, United States • Danbury, Connecticut, United States +8 more locations

COMPLETED< 1 mile

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

NCT00370214

The REVEAL Registry™ is a multicenter, observational, U.S.-based study of the clinical course and disease management of pulmonary arterial hypertension (PAH) patients. All consecutive consenting patients diagnosed with WHO Group I PAH according to specific hemodynamic criteria at participating institutions will be enrolled. Participating patients will be followed for a minimum of five years from the time of enrollment.

Pulmonary Hypertension

Actelion3,515 participantsStarted Mar 2006

Birmingham, Alabama, United States • Tucson, Arizona, United States • La Jolla, California, United States +51 more locations

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

Hypertension Trials in Other Cities

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension

Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons

Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401

Computerized Health Education to Promote Physical Activity

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

Secondary Prevention of Small Subcortical Strokes Trial

Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension

Effect of a Community-based Nursing Intervention on Mortality in Chronically Ill Older Adults

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension

The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

Other Conditions in Philadelphia